| Treatment options for female sexual arousal disorder: part II. | |
| | |
MedLine Citation:
|
PMID: 20949811 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Female sexual arousal disorder (FSAD) occurs when a woman experiences distress due to the inability to attain or maintain adequate vaginal lubrication. Many treatments are still under investigation, and at this time, there are no FDA-approved medications available for the treatment of FSAD. Treatment options include "off-label" medications, vaginal estrogen, compounded preparations, and over-the-counter products. |
| | |
Authors:
|
Melissa Feldhaus-Dahir |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Urologic nursing Volume: 30 ISSN: 1053-816X ISO Abbreviation: Urol Nurs Publication Date: 2010 Jul-Aug |
Date Detail:
|
Created Date: 2010-10-18 Completed Date: 2010-11-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8812256 Medline TA: Urol Nurs Country: United States |
Other Details:
|
Languages: eng Pagination: 247-51 Citation Subset: N |
Affiliation:
|
Sexual Medicine & Wellness Center, Methodist Physicians Women's Clinic, Omaha, NE, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Intravaginal Adrenergic alpha-2 Receptor Antagonists / therapeutic use Alprostadil / therapeutic use Estrogen Replacement Therapy Female Glycosides / therapeutic use Humans Lubricants Minerals / therapeutic use Nonprescription Drugs / therapeutic use Off-Label Use Piperazines / therapeutic use Plant Preparations / therapeutic use Purines / therapeutic use Sexual Dysfunction, Physiological / etiology, prevention & control* Sexual Dysfunctions, Psychological / etiology, prevention & control* Suction Sulfones / therapeutic use Vasodilator Agents / therapeutic use Yohimbine / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic alpha-2 Receptor Antagonists; 0/ArginMax; 0/Glycosides; 0/Lubricants; 0/Minerals; 0/Nonprescription Drugs; 0/Piperazines; 0/Plant Preparations; 0/Purines; 0/Sulfones; 0/Vasodilator Agents; 139755-83-2/sildenafil; 146-48-5/Yohimbine; 745-65-3/Alprostadil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Getting ready for certification: bladder cancer.
Next Document: Gelnique (oxybutynin chloride) 10% gel for overactive bladder.